ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Analyst Earnings Estimates
NASDAQ:ARQT - Nasdaq - US03969K1088 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.69M | 59.606M 1,515.34% | 189.17M 217.37% | 294.42M 55.64% | 431.61M 46.60% | 575.89M 33.43% | 724.32M 25.77% | 832.34M 14.91% | 906.51M 8.91% | 982.14M 8.34% | 1.044B 6.30% | ||
| EBITDA YoY % growth | -206.08M -50.94% | -300.7M -45.91% | -239.58M 20.33% | -152.443M 36.37% | -120.88M 20.70% | -40.177M 66.76% | 132.09M 428.77% | 232.76M 76.21% | 321.5M 38.13% | 400.76M 24.65% | 494.8M 23.47% | N/A | |
| EBIT YoY % growth | -206.53M -51.14% | -301.63M -46.05% | -241.101M 20.07% | -151.42M 37.20% | -97.211M 35.80% | 12.446M 112.80% | 171.91M 1,281.25% | 289.8M 68.58% | 379.05M 30.80% | 436.8M 15.24% | 420.1M -3.82% | 455.27M 8.37% | |
| Operating Margin | N/A | -8,174.25% | -404.49% | -80.04% | -33.02% | 2.88% | 29.85% | 40.01% | 45.54% | 48.18% | 42.77% | 43.61% | |
| EPS YoY % growth | -4.16 -6.94% | -5.65 -35.82% | -3.92 30.62% | -1.35 65.59% | -0.85 37.31% | 0.05 106.35% | 1.56 2,807.09% | 2.37 52.16% | 2.76 16.24% | 3.01 9.02% | 2.43 -19.21% | 2.55 5.04% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 63.88% | -0.29 9.69% | -0.25 40.91% | -0.22 34.06% | -0.28 -7.84% |
| Revenue Q2Q % growth | 61.363M 353.67% | 63.671M 28.45% | 71.13M 130.51% | 77.483M 73.13% | 83.589M 36.22% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -27.116M 55.67% | -29.55M 6.55% | -23.934M 52.21% | -20.07M 48.63% | -16.932M 37.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.33 54.79% | -0.43 | 0.10 | 22.44% |
| Q2 2024 Q2Q % growth | -0.42 63.79% | -0.53 | 0.11 | 20.28% |
| Q1 2024 Q2Q % growth | -0.32 75.57% | -0.74 | 0.42 | 57.02% |
| Q4 2023 Q2Q % growth | -0.72 38.98% | -0.79 | 0.07 | 8.92% |
| Q3 2023 Q2Q % growth | -0.73 61.38% | -0.87 | 0.14 | 16.54% |
| Q2 2023 Q2Q % growth | -1.16 11.45% | -1.28 | 0.12 | 9.03% |
| Q1 2023 Q2Q % growth | -1.31 -3.15% | -1.31 | 0.00 | 0.03% |
| Q4 2022 Q2Q % growth | -1.18 16.90% | -1.45 | 0.27 | 18.71% |
| Q3 2022 Q2Q % growth | -1.89 -65.79% | -1.70 | -0.19 | -11.03% |
| Q2 2022 Q2Q % growth | -1.31 -55.95% | -1.46 | 0.15 | 10.40% |
| Q1 2022 Q2Q % growth | -1.27 -67.11% | -1.53 | 0.26 | 17.10% |
| Q4 2021 Q2Q % growth | -1.42 -79.75% | -1.52 | 0.10 | 6.88% |
| Q3 2021 Q2Q % growth | -1.14 -12.87% | -1.17 | 0.03 | 2.95% |
| Q2 2021 Q2Q % growth | -0.84 10.64% | -0.92 | 0.08 | 8.67% |
| Q1 2021 Q2Q % growth | -0.76 33.91% | -0.98 | 0.22 | 22.18% |
| Q4 2020 Q2Q % growth | -0.79 87.22% | -0.90 | 0.11 | 11.99% |
| Q3 2020 Q2Q % growth | -1.01 | -0.92 | -0.09 | -9.72% |
| Q2 2020 Q2Q % growth | -0.94 | -0.86 | -0.08 | -9.28% |
| Q1 2020 Q2Q % growth | -1.15 | -0.94 | -0.21 | -22.99% |
| Q4 2019 Q2Q % growth | -6.18 | -9.39 | 3.21 | 34.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 44.755M 17.44% | 38.369M | 6.386M | 16.64% |
| Q2 2024 Q2Q % growth | 30.858M 494.57% | 29.662M | 1.196M | 4.03% |
| Q1 2024 Q2Q % growth | 49.569M 1,682.42% | 14.974M | 34.595M | 231.03% |
| Q4 2023 Q2Q % growth | 13.526M 356.96% | 11.567M | 1.959M | 16.94% |
| Q3 2023 Q2Q % growth | 38.109M 5,120.41% | 33.485M | 4.624M | 13.81% |
| Q2 2023 Q2Q % growth | 5.19M | 4.692M | 498K | 10.61% |
| Q1 2023 Q2Q % growth | 2.781M | 3.2M | -419K | -13.09% |
| Q4 2022 Q2Q % growth | 2.96M | 2.247M | 713K | 31.73% |
| Q3 2022 Q2Q % growth | 730K | 663K | 67K | 10.11% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 10.35% | 10.35% | 2.32% | 2.32% |
| Revenue | 10.01% | 10.01% | 0.68% | 2.93% |